CG
LLY icon

Corundum Group’s Eli Lilly LLY Stock Holding History

Corundum Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
1,671
+159
+11% +$161K 0.51% 41
2025
Q4 		$1.62M Sell
1,512
-101
-6% -$96.6K 0.55% 36
2025
Q3 		$1.23M Sell
1,613
-16
-1% -$11.9K 0.51% 47
2025
Q2 		$1.27M Buy
1,629
+584
+56% +$454K 0.56% 43
2025
Q1 		$863K Sell
1,045
-1,673
-62% -$1.39M 0.41% 58
2024
Q4 		$2.1M Buy
2,718
+1,656
+156% +$1.37M 0.78% 31
2024
Q3 		$941K Sell
1,062
-2,867
-73% -$2.58M 0.43% 55
2024
Q2 		$3.56M Buy
3,929
+2,427
+162% +$1.94M 1.39% 18
2024
Q1 		$1.17M Sell
1,502
-64
-4% -$45.5K 0.56% 40
2023
Q4 		$913K Buy
1,566
+8
+0.5% +$4.67K 0.46% 50
2023
Q3 		$837K Sell
1,558
-462
-23% -$238K 0.48% 48
2023
Q2 		$947K Sell
2,020
-2,474
-55% -$1.04M 0.47% 54
2023
Q1 		$1.54M Buy
4,494
+2,320
+107% +$782K 0.73% 42
2022
Q4 		$795K Buy
2,174
+49
+2% +$17.4K 0.45% 58
2022
Q3 		$687K Buy
2,125
+88
+4% +$27.9K 0.43% 60
2022
Q2 		$660K Buy
2,037
+59
+3% +$17.7K 0.45% 58
2022
Q1 		$566K Buy
1,978
+153
+8% +$39.4K 0.53% 71
2021
Q4 		$504K Buy
1,825
+80
+5% +$20.3K 0.33% 58
2021
Q3 		$403K Buy
1,745
+114
+7% +$28.1K 0.3% 58
2021
Q2 		$374K Sell
1,631
-151
-8% -$30.3K 0.25% 61
2021
Q1 		$333K Buy
1,782
+16
+0.9% +$3.13K 0.26% 63
2020
Q4 		$298K Buy
1,766
+140
+9% +$20.9K 0.25% 66
2020
Q3 		$241K Buy
1,626
+59
+4% +$9.13K 0.23% 67
2020
Q2 		$257K Sell
1,567
-215
-12% -$33K 0.31% 41
2020
Q1 		$247K Sell
1,782
-139
-7% -$19.1K 0.35% 40
2019
Q4 		$252K Buy
1,921
+87
+5% +$10.1K 0.26% 59
2019
Q3 		$205K Sell
1,834
-2
-0.1% -$223 0.24% 61
2019
Q2 		$203K Buy
1,836
+14
+0.8% +$1.65K 0.23% 65
2019
Q1 		$236K Sell
1,822
-4,154
-70% -$505K 0.27% 51
2018
Q4 		$692K Buy
+5,976
New +$668K 0.64% 28

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Corundum Group's LLY Position: Q1 2026 in Review

Corundum Group increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $161K and bringing the position to 1,671 shares worth $1.54M. The position accounts for 0.51% of the portfolio, ranked #41.

Corundum Group first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.56M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Corundum Group held 1,671 shares of Eli Lilly worth $1.54M as of Q1 2026.
  • Corundum Group bought 159 Eli Lilly shares in Q1 2026, an estimated $161K.
  • Eli Lilly made up 0.51% of Corundum Group's portfolio in Q1 2026, its #41 holding.
  • Corundum Group first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Corundum Group's Eli Lilly position peaked at $3.56M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.